Our previous analysis using public databases revealed an increase in C3G mRNA levels in patient tumor liver samples as compared to non-pathological liver [32], which suggests that C3G might play a role in HCC. This evidence concerns the gene RAPGEF1 and hepatocellular carcinoma.